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SUMMARY.-Sprague-Dawley rats aged50 days were given single oral doses of
the carcinogen, DMBA.
Rats receiving the carcinogen at the same stage of the oestrous cycle were
grouped together and mammary tumour production was compared between
these groups.
When the carcinogen was given during di-oestrus the mean number of
tumours per animal was significantly greater than when it was given at other
stages in the oestrous cycle. There was considerable variation in total tumour
yield from one batch of animals to another.
IN any batch ofrats given asingle oraldose of9,10-dimethyl-1,2-benzanthracene
(DMBA) for the production ofmammary carcinomas some rats will develop several
tumours, others only a few and some may develop no tumours at all.
The yield of tumours from such rats is greatly reduced by castration but this
can be reversed by replacement therapy using ovarian grafts (Dao, 1962). In
certain doses oestradiol given to intact rats depresses, and progesterone enhances,
mammary tumour production (Huggins, Grand and Brillantes, 1959, 1961).
Tumour production is diminished in hypophysectomized animals but this effect
also can be partly reversed by replacement ofappropriate hormones (Young, 1961).
Tumour production is reduced in rats made hypothyroid surgically (Jull and
Huggins, 1960) or chemically (Helfenstein, Young and Currie, 1962) or made
lhyperthyroid by relatively large doses of 1-thyroxine (Jull and Huggins, 1960).
There is thus ample evidence that hormones which affect mammary epithelium,
plays a large part in determining the susceptibility of rats to orally administered
carcinogens. It seemed possible therefore that variations in response might be
related to cyclical variations in circulating oestrogens and hence to the phase ofthe
oestrous cycle during which the carcinogen was given.
Experiments were set up to investigate this question and this paper records our
results.
MATERIALS AND METHODS
The rats were virgin female Sprague-Dawley. They were Caesarean derived,
free from most normal pathogens (SPF) and random bred in the laboratories ofthe
Imperial Cancer Research Fund. They were obtained at about 28 days of age,
were housed 5 to a cage and were kept in an ambient temperature of about 700 F.
(21° C.) with the lighting controlled to give equal periods of light and darkness.DMBA MAMMARY CARCINOMAS IN RATS
A pelleted diet (formula GR3E, manufactured by Messrs. Dicksons of Ware) and
water were both allowed ad libitum.
From about the 43rd day ofage vaginal smears were taken at the same time on
each day for 5 days per week and for 2 consecutive weeks. These were stained with
Pasini's stain and were used to determine the stage of the oestrous cycle on the
50th day ofage when each rat was given by stomach tube 2 ml. of corn oil contain-
ing 30 mg. of DMBA. Four weeks later weekly examinations for the presence of
tumours were started. When the tumours hadgrown to about 1 cm. diameter they
were removed under anaesthetic and slices were fixed in Bouin's fluid. They were
embedded in paraffin wax and histological sections were cut and stained with
haematoxylin and eosin. All tumours were examined histologically by one of us
(S.Y.). Six experiments were set up in this way with a total of 296 rats. The
experiments were assessed 20 weeks after the carcinogen was given when all
surviving animals were killed.
RESULTS
Two hundred and sixty-one rats survived to the end ofthe experiments and 199
ofthem developed mammary tumours. Out ofthe 987 tumours produced 965 had
the histology of adenocarcinomas and 22 were fibroadenomas.
The experiments were intended to examine the frequency with which mammary
adenocarcinomas developed under certain circumstances. Towards the end ofthe
experiments very few new carcinomas were being detected, whereas fibroadenomas
were found with increasing frequency. It is known (Daniel and Pritchard, 1964)
that the induction time of fibroadenomas is much longer than that of carcinomas.
Since the peak offibroadenoma production was not reached these tumours have not
been included in our tables.
Details of our results are given in Table I which shows:
(a) The number ofanimals at risk for each experiment and for each stage ofthe
cycle.
(b) The numbers of rats developing carcinomas for each experiment and for
each stage of the cycle.
(c) The numbers of carcinomas produced by rats at risk for each experiment
and for each stage of the cycle.
The percentage of rats which developed mammary adenocarcinomas was
comparatively uniform throughout the various stages ofthe oestrous cycle (P is not
significant), on the other hand the total number of carcinomas observed was higher
than the expected value in the di-oestrous group and this difference was statistically
significant, P < 0 001. Similarly a comparison of the carcinomas produced by
different experimental batches of animals showed considerable departure from the
expected yield and these differences also were highly significant (P < 0-001).
Analysis of variance was carried out on (a) the proportion of rats developing
carcinomas and (b) the mean numbers oftumours per rat at risk for all experiments
and for all stages of the cycle. Variance was almost equally divided between
stages of the cycle and batches of animals, each was significant, the former being
slightly more so than the latter.
The mean induction periods of carcinomas induced in these experiments are
presented in Table II. From inspection it did not appear that the induction
period was affected by the stage ofthe cycle any more than by different batches of
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animals. This was verified by analysis of variance which indicated that the
variances were not significant and did not differ significantly from one another.
TABLE II.-Mean Indauction Periods in Weeks of Carcinomas for Rats Given
Oral DMBA at Different Times DuriMg the Oestrous Cycle
Exp. No. Di-oestrus Pro-oestrus Oestrus Met-oestrus Means
A 12-24 12-50 13-93 14-26 13-30
B 1298 1518 15-57 . 15*18 . 14-18
C 13-59 . 13-79 14-03 14-36 13-90
D 1331 14*90 1380 1469 . 14-12
E 1092 7-5 10*83 10 62 10*46
F 10-68 . 1111 . 10-14 11-83 1118
AMeans 1254 13-35 13-27 13-54 13-22
DISCUSSION
If our results are representative it is clear that the average number of tumours
per rat in animals given oral DMBA is likely to be greater ifthe carcinogen is given
during the phase of di-oestrus. This difference in tumour incidence between
phases of the cycle might be due to differences in the numbers of cells undergoing
malignant change or to differences in the numbers ofsuch malignant cells that have
been able to multiply, form tumours, and continue growing.
Maximum concentration of DMBA in the mammary fat pads occurs within
24 hours ofan oral dose (Wieder, Thatcher and Shimkin, 1967) and it may well take
longer to reach its peak in the epithelial cells. The circulating levels ofoestrogens
are at their highest in late di-oestrus and early pro-oestrus and fall to their lowest
level in early oestrus (Barnea, Gershonowitz and Shelesnyak, 1968; Hori, Ide and
Miyake, 1968; Leroy, Galand and Chretien, 1969). The secretion of progesterone
is believed to start in late pro-oestrus (Hori et al., 1968; Barnea et al., 1968) and it is
therefore present and rising when oestrogen activity is lowest. Huggins et al.
(1959) have shown that carcinogenic activity in mammary glands is diminished by
oestrogens but increased by progesterone. Thus, it appears that for the car-
cinogen to reach its highest concentration in mammary epithelium when ovarian
hormones most favour carcinogenesis it would probably have to be given during
di-oestrus.
On the other hand the mammary glands of 50-day-old rats contain many
millions ofepithelial cells and mitotic counts of 1-2 per cent are found during each
phase of the oestrous cycle (Cowan, unpublished results) so that very many cells
must also be present in the other stages of the cell cycle. If the sensitivity of
mammary epithelium is related solely to the phase ofthe proliferative cycle and to
the concentrations of ovarian hormones and carcinogen, it is difficult to see why
many more tumours do not develop. It seems probable that other factors are
involved, which might reduce the chances of a malignant transformation or
prevent the growth of malignant foci or prove lethal to such foci as have actually
formed. Our experiments give no information on these questions.
We are indebted to Mr. W. J. Berry, Mr. J. D. G-ilbert and Miss C. E. Murkin for
technical, and to Mrs. K. P. Swales for secretarial assistance.
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